WALKING PNEUMONIA - NOT ALWAYS SO TIMID A CASE OF SEVERE ARDS DUE TO FULMINANT MYCOPLASMA PNEUMONIA
Open Access
- 3 July 2025
- journal article
- case report
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (4) , 88-91
Abstract
Mycoplasma pneumoniae pneumonia (MPP) most commonly presents as bronchitis or as a self-limited ‘walking’ community acquired pneumonia. A fulminant form of MPP may occur in 0.5% to 2% of patients and is characterized by rapidly progressive respiratory failure and Acute respiratory distress syndrome (ARDS). Our case highlights the importance of considering fulminant MPP as a cause of ARDS, especially in the young adult and middle-aged population. We review the current literature and management principles of this rare disease with an emphasis on antibiotic stewardship and corticosteroid therapy. Further research is needed to better understand patterns of antibiotic resistance and to establish management guidelines for fulminant MPP.Keywords
This publication has 10 references indexed in Scilit:
- Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired PneumoniaChest, 2022
- Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae InfectionsJAMA Network Open, 2022
- Acute Hypoxic Respiratory Failure and Septic Shock Secondary to Mycoplasma Pneumoniae Pneumonia Complicated by Heroin OverdoseCureus, 2020
- Tigecycline in the treatment of fulminant Mycoplasma pneumoniae pneumonia non-responsive to azithromycin and fluoroquinoloneMedicine, 2020
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Clinical Features of Severe or Fatal Mycoplasma pneumoniae PneumoniaFrontiers in Microbiology, 2016
- Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adultsJournal of Infection and Chemotherapy, 2015
- Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: A review of the Japanese literatureJournal of Infection and Chemotherapy, 2014
- Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unitJournal of Medical Microbiology, 2007
- Fulminant Mycoplasma pneumoniae pneumonia.1995